Tagungen und Workshops zum Thema Pharmakologie und Arzneimittelentwicklung

Conference-Service.com stellt der Öffentlichkeit ein Kalendarium wichtiger Konferenzen, Symposien und sonstiger Tagungen im wissenschaftlich-technischen Bereich zur Verfügung. Obwohl das Verzeichnis mit großer Sorgfalt zusammengestellt und ständig aktualisiert wird, weisen wir auf die Möglichkeit von Fehlern ausdrücklich hin. Bitte vergewissern Sie sich immer beim Veranstalter, bevor Sie über die Teilnahme oder Nichtteilnahme an einer Konferenz entscheiden.

Organisatoren können kostenlos ihre Konferenzankündigungen veröffentlichen.

ALLE LÄNDER

1.
 
Keystone Symposia: Biobetters and Next-Generation Biologics: Innovative Strategies for Optimally Effective Therapies
ID
830073
Termin
22. Jan 2017 - 26. Jan 2017
Ort
Snowbird, Utah, Vereinigte Staaten
Zusammenfassung
The purpose of this meeting is to examine different approaches for treatment of cancer and other diseases (e.g., fibrosis, autoimmunity and inflammatory diseases). The program will provide insights from academic and industry scientists on innovative biologics technologies and treatment strategies for ameliorating disease in an effort to identify synergies and opportunities to cross-fertilize approaches. Furthermore, the meeting includes perspectives from the US Food & Drug Administration and how the outlined strategies will impact the drug review and approval process. The intention is to better inform meeting attendees of current/future strategies for treating disease and best practices for transforming concepts into approved drugs.
Kontakt
Attendee Services;     Tel.: [970-262-1230 or 800-253-0685];     Email: info@keystonesymposia.org
Themen
Cancer, drug discovery, immunology
2.
 
Drug Development, Pharmacokinetics and Imaging
ID
828740
Termin
23. Jan 2017 - 27. Jan 2017
Ort
Oxford, Großbritannien
Zusammenfassung
The Drug Development, Pharmacokinetics and Imaging module is a one-week module of the MSc in Experimental Therapeutics programme. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the module will be led by Dr Paul Brennan, and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists.
Kontakt
Course Administrator;     Tel.: [+44(0) 01865 286955];     Email: expther@conted.ox.ac.uk
3.
 
FDA Scrutiny of Promotion and Advertising Practices
ID
852522
Termin
24. Jan 2017 - 25. Jan 2017
Ort
San Francisco, Vereinigte Staaten
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
fda's advertising and promotion requirements, fda regulations for labelling, fda warning letter, fda legal authority, ftc, mass media, doj, off label, fda guidance, custom device promotion, fda compliance seminar
4.
 
Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment - Issues and Solutions
ID
855419
Termin
26. Jan 2017 - 27. Jan 2017
Ort
Orlando, Vereinigte Staaten
Zusammenfassung
Raw material requirements in a cGMP environment are often overlooked as a company develops new products. Depending on the product being developed, e.g., tablets and capsules vs. biotechnology products, as few as fifteen to twenty or as many as sixty raw materials need to be sourced before the process can be moved from initiation through completion.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
Raw material requirements in a cgmp environment training, compendial and non-compendial testing, ASQ on sample size, ICH Q9
5.
 
Latin America: Regulatory Compliance Requirements for Life Science Products (Focus: Brazil, Mexico, Argentina)
ID
855396
Termin
26. Jan 2017 - 27. Jan 2017
Ort
San Francisco, Vereinigte Staaten
Zusammenfassung
This two-day comprehensive Course on Latin America Regulatory compliance requirements will cover topics ranging from pre-clinical and clinical requirements through product registration, amendments and renewals across Pharmaceuticals, Biologics, Medical Devices and Combination Products. The Course will address the structure of the regulatory agencies in Latin America and discuss local cultural nuances to help you be successful in working with the regulators.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
Latin America regulations, Latin America life sciences regulations, Latam life sciences regulatory requirements, Latin America pharmaceutical regulations, Latin America medical device regulations, Latin America biologics regulations
6.
 
Supplier and Contractor Qualification and Control for Life Science Industry
ID
855428
Termin
26. Jan 2017 - 27. Jan 2017
Ort
Tampa, Vereinigte Staaten
Zusammenfassung
This two-day course focuses on the processes associated with the acquisition of products, materials and services that fuel and support the organization’s product manufacturing and marketing. These cross-functional processes are complex and result in conflicting objectives between decision-makers. Management is responsible for organizing and providing resources and the more they understand, the more effectively they can manage. Note: Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
Supplier control program, contractor qualification, Part 211, subpart e-control, drug product containers, ICH Q7A, section VII, materials management part 820
7.
 
Essentials Of USP Microbiology - Reading Between the Lines of the USP General and Information Microbiology Chapters
ID
855350
Termin
31. Jan 2017 - 01. Feb 2017
Ort
Orlando, Vereinigte Staaten
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
USP Microbiology, USP microbiology chapters, USP general, USP General Chapter Changes, USP Chapters, USP document, HVAC, USP, EP and JP
8.
 
Navigating the Maze for Post-Market Compliance -- Complaint Handling, MDRs, Recalls and Proposed Guidance on FDA Risk Benefits
ID
868052
Termin
02. Feb 2017 - 03. Feb 2017
Ort
Tampa, Vereinigte Staaten
Zusammenfassung
This interactive one and a half day course led by Ms. Rita Hoffman, Former FDA CDRH Recall Branch Chief, who has more than 36 years’ experience with the FDA will provide the participants tools to minimize risk of regulatory enforcement actions.

During the seminar, Ms. Hoffman will explain proper handling of complaints reportable or non-reportable, product complaint handling and documentation, how and when to file Medical Device Reports (MDR), effective and appropriate communication with the appropriate regulatory agencies in the event of a recall. She will also discuss how to conduct a correction and removal actions to avoid a recall crisis, including required recordkeeping, expectation from FDA and other regulatory agencies in the event of a recall and key factors in implementing and maintaining compliance with the regulations and real life experiences of FDA.Note:Use coupon code NB5SQH8N and get 10% off on registration.

Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
medical device recalls seminar, medical device regulations seminar, medical device reporting, medical device complaint management, medical device complaint handling
9.
 
Compliance Risk Management in Medical Devices, Pharmaceuticals, and Combination Products
ID
868073
Termin
02. Feb 2017 - 03. Feb 2017
Ort
Tampa, Vereinigte Staaten
Zusammenfassung
Effective risk management is the hallmark of a successful corporation. Increasingly, it is also the hallmark of a compliant corporation. While Medical Devices, Pharmaceuticals, and Combination Products have had unique histories for the evolution of risk management, the management of compliance risk is a common business process for all three areas.Enterprise Risk Management (ERM) is the generic term for managing the risks of an organization. ISO 31000 is the ERM ISO Standard. This standard provides guidance for organizations on implementing ERM solutions. ISO 9001 is the Quality Systeme Standard. ISO 9001 now requires to establish “risk-based thinking.” As a result, ISO 13485, the International Quality System Standard for Medical Devices, has been revised to include requirements for firms to implement Compliance Risk Management. These requirements are in addition to the requirements as currently defined by ISO 14971, the International Standard for Risk Management of Medical Devices.Note:Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
Enterprise Risk Management (ERM) Training, ISO 31000, ERM solutions, ISO 14971 Training, medical device risk management training
10.
 
9ITIM — 9th Immunotherapeutics & Immunomonitoring Conference
ID
854160
Termin
06. Feb 2017 - 07. Feb 2017
Ort
San Diego, Vereinigte Staaten
Zusammenfassung
GTCbio is proud to present the 9th Immunotherapeutics & Immunomonitoring Conference, to be held on February 6-7, 2017 in San Diego, CA.
Kontakt
Kristen Starkey;     Tel.: [6262566405];     Email: infogtcbio@gtcbio.com
Themen
Immunotherapy, Immune therapeutics. Immunotherapeutics, Immunomonitoring, Immunodiagnostics
11.
 
Chemical Development Scale-Up in the Fine Chemical and Pharmaceutical Industries
ID
858678
Termin
06. Feb 2017 - 08. Feb 2017
Ort
Mumbai, Indien
12.
 
7th Ubiquitin Research & Drug Discovery Conference
ID
855635
Termin
08. Feb 2017 - 09. Feb 2017
Ort
San Diego, Vereinigte Staaten
Zusammenfassung
We are pleased to invite you to GTCbio's 7th Ubiquitin Research & Drug Discovery Conference, which will take place February 8-9, 2017 in San Diego, CA. This conference will provide a forum for researchers from industry and academia to learn about recent advances in basic science and drugs that target the ubiquitin/proteasome system. Hot topics such as autophagy in cancer, developments with deubiquitinating enzymes, and novel drug targets in the ubiquitin system will be covered. Please join us not only for updates on the latest scientific research, but also for networking sessions between colleagues from both industry and academia in order to get the most comprehensive exchange of ideas.
Kontakt
Kristen Starkey;     Tel.: [6262566405];     Email: infogtcbio@gtcbio.com
13.
 
3rd Protease Inhibitors in Drug Discovery Conference
ID
855623
Termin
08. Feb 2017 - 09. Feb 2017
Ort
San Diego, Vereinigte Staaten
Zusammenfassung
We are pleased to announce the 3rd Protease Inhibitors in Drug Discovery Conference, to be hosted by GTCbio on February 8-9, 2017 in San Diego, CA. Though protease inhibitors hold great therapeutic promise in areas such as inflammation, cardiovascular diseases, and cancer, researchers in the field are still overcoming the challenge of specificity for drug design. This meeting will provide a forum for scientists from both industry and academia to share recent advances in protease inhibitor research, from biological functions to translational aspects for drug discovery. Speakers will cover topics such as regulation of proteases by exosites, drug design of protease inhibitors, membrane-associated proteolysis, and many more. In addition to cutting-edge scientific presentations, attendees will be able to form new connections during dedicated networking sessions.
Kontakt
Kristen Starkey;     Tel.: [6262566405];     Email: infogtcbio@gtcbio.com
14.
 
SOPs for FDA-Regulated Industry: Best Practices to Withstand FDA Expectations
ID
868138
Termin
09. Feb 2017 - 10. Feb 2017
Ort
Scottsdale, Vereinigte Staaten
Zusammenfassung
One of the best ways to ensure that an organization meets its regulatory obligations is to follow SOPs. SOPs are standardized procedures and processes prepared with enough detail to ensure that tasks are performed consistently each time they are done. SOPs are also required to be in compliance with regulations and guidelines internationally, across all regulated functions. Lack of SOPs and not following SOPs are often cited in regulatory inspections as deficiencies that must be corrected. Poorly prepared SOPs or poor compliance with existing SOPs can compromise a drug development program, an effective quality system, and may result in product recalls.Note:Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
FDA SOP requirements, FDA SOPs, FDA regulated industry SOP types, FDA SOP components, SOP training, SOP implementation, SOP template, SOP numbering system
15.
 
Validation, Verification and Transfer of Analytical Methods (Understanding and implementing guidelines from FDA/EMA, USP and ICH)
ID
868137
Termin
09. Feb 2017 - 10. Feb 2017
Ort
Burlingame, Vereinigte Staaten
Zusammenfassung
Analytical methods and procedures should be validated to ensure reliability, consistency and accuracy of analytical data. Compendial methods should be verified to demonstrate the suitability of laboratories to successfully run the method and when methods are transferred between laboratories successful transfer should be demonstrated through testing. In case a laboratory wants to use an alternative method instead of a compendial method, equivalency of the alternative method to the compendial method should be demonstrated.Note:Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
Laboratory compliance, Analytical methods, data, procedures, compendial methods, Method validation and transfer, equivalency testing, FDA inspection
16.
 
FDA Recalls - Before You Start, and After You Finish
ID
868136
Termin
09. Feb 2017 - 10. Feb 2017
Ort
San Jose, Vereinigte Staaten
Zusammenfassung
FDA's recall authority and program launches you into a project of crisis management. You will learn how to establish a roadmap for conducting recalls. The knowledge you gain will sharpen your recall management decisions and strategy. You will learn how to use the FDA's health risk criteria so you can develop effective recall procedures. One critical aspect of recalls involves the identification of the root cause of the recall and how you could or should prevent that problem from happening again. Your corrective and preventive action program (CAPA) and quality assurance functions require a rigorous approach to prevent a chronic history of recalls. Reiterative recalls lead the FDA to the conclusion that,
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
FDA Recall, FDA recall classes, FDA recall guidance, FDA recall procedures, regulatory management, CAPA, FDA inspection, Recall Regulations
17.
 
11th ANNUAL DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCE
ID
843004
Termin
12. Feb 2017 - 14. Feb 2017
Ort
San Diego, Kalifornien, Vereinigte Staaten
Zusammenfassung
This didactic conference will educate scientists on the processes of translating basic research into novel therapies and will leave participants with a strong knowledge base and relevant resources to address the associated barriers and challenges in developing a drug.
Kontakt
Sara Classen;     Tel.: [Tel: +1.212.901.8009];     Email: sclassen@alzdiscovery.org
Themen
Neurodegeneration, Drug discovery, CNS, Alzheimer’s Disease
18.
 
The 7th Annual World ADC Berlin Summit
ID
856360
Termin
14. Feb 2017 - 16. Feb 2017
Ort
Berlin, Deutschland
19.
 
SBCADD`2017 — 9th National Symposium cum Workshop on “Recent Trends in Structural Bioinformatics and Computer Aided Drug Design”
ID
853104
Termin
14. Feb 2017 - 17. Feb 2017
Ort
Karaikudi, Indien
Zusammenfassung
SBCADD’2017 would like to take this wonderful privilege to invite you all to the 9thNational Symposium cum Workshop” going to be held during February 14th – 17th 2017, on the theme of “Recent Trends in Structural Bioinformatics and Computer Aided Drug Design” seeks to continue the good synergy obtained in the previous edition, providing a discussion forum from scientists, researchers, students and industrials about the latest ideas and realizations in the foundations, theory, models and applications for interdisciplinary and multidisciplinary research encompassing disciplines of Structural Biology, Molecular Biology, Structural Bioinformatics, Computer Aided Drug Design and Pharmacogenomics. In recent years, Computational Biology and Medical Informatics have seen significant advances driven by computational techniques making Bioinformatics and Computational Biology among the most vibrant research areas that could accelerate translational research comprising of the development and discovery of drugs against combating diseases that could enhance the livelihood and life expectancy of the individuals. The aim of SBCADD’2017 is to create a friendly environment that could lead to the establishment or strengthening of scientific collaborations and exchanges among attendees, and therefore, participation at SBCADD’2017 would provide an excellent opportunity to keep up with the cutting-edge research in such enlivening topics mentioned above and to network with other members of our community. We cordially invite you to submit abstract and participate in Symposium cum Workshop.
Kontakt
Dr. Sanjeev Kumar Singh;     Tel.: [+91 – 4565 - 223342];     Email: dbiconf@gmail.com
Themen
SBCADD'2107, Sanjeevslab, Dr. Sanjeev Kumar Singh, sanjeevslab.org, bioinfoau.org
20.
 
Biologistics World Asia 2017
ID
827154
Termin
15. Feb 2017 - 16. Feb 2017
Ort
Singapore, Singapur
Zusammenfassung
Biologistics World Asia will be the MOST Targeted event in Asia that focuses on cold- chain logistics for biomedical products. Bioplogistics World Asia 2017 will be attended by decision makers from regional and international biopharmaceuticals and biotechnology firms, top CMOs and CROs, government organizations and key global and Asian regulators. It’s your one stop solution to reach out to Asia’s logistics and supply chain industry!
Kontakt
Andrew Darwitan;     Tel.: [+65 3109 0156];     Email: andrew.darwitan@imapac.com
21.
 
Early Access Programmes & Compassionate Use in the EU
ID
854525
Beginn
20. Feb 2017
Ort
Düsseldorf, Meliá Düsseldorf, Deutschland
Zusammenfassung
This seminar provides you with a detailed overview of early access possibilities in the EU in general as well as in Germany, the UK, Spain and France in particular. After having attended the seminar, you will be aware of the available options for, and the arising challenges of, bringing your pharmaceuticals to the European market as fast as possible. Specifically, topics such as eligibility to the various programmes, data requirements and reimbursement options will be discussed in order to acquire a deep understanding of how patients could benefit from your products at the earliest possible.
Kontakt
Dr. Henriette Wolf-Klein;     Tel.: [+49 6221 500-680];     Email: h.wolf-klein@forum-institut.de
Themen
medical affairs, market access, healthcare management, early access in the EU legal framework, compassionate use in France - ATU as best practice?, early access in the UK - the early access to medicines scheme, early access possibilities in Spain, the German compassionate use programme - lessons learnt
22.
 
Marketing Authorisation in Russia, Belarus, Kazakhstan and Ukraine
ID
854548
Termin
20. Feb 2017 - 21. Feb 2017
Ort
Berlin, Mercure Hotel MOA Berlin, Deutschland
Zusammenfassung
Legislation for the registration and circulation of pharmaceutical products is changing significantly, under pressure from the planned Customs Union. This seminar provides you with in-depth knowledge on the current challenges when applying for a new marketing authorisation and an overview of maintenance activities in the EAEU countries. The regulatory framework in Ukraine, which is not an EAEU member state, will also be covered. After having attended the seminar you will know how to currently handle registration and distribution in Russia, Belarus, Kazakhstan and Ukraine, and which legislation changes are in progress.
Kontakt
Dr. Henriette Wolf-Klein;     Tel.: [+49 6221 500-680];     Email: h.wolf-klein@forum-institut.de
Themen
Regulatory Affairs, distribution in EAEU countries, national registration in Belarus, Kazakhstan and Ukraine, EAEU - goals and timelines for implementation, local marketing authorisation in Russia, Marketing authorisation in the EAEU region, Maintenance duties
23.
 
World ADC Berlin — The 7th Annual World ADC Berlin
ID
845022
Termin
20. Feb 2017 - 22. Feb 2017
Ort
Berlin, Deutschland
Kontakt
Jenny Barlow;     Tel.: [+1 212 537 5898];     Email: info@hansonwade.com
Themen
Antibody drug conjugates, Antibody-drug conjugates, ADCs/ADC
Verwandte Fachgebiete
24.
 
Vaccines-2017 — International Conference on Vaccines-2017
ID
811250
Termin
20. Feb 2017 - 22. Feb 2017
Ort
Baltimore, Vereinigte Staaten
Zusammenfassung
This scientific conference will bring an opportunity to share potential benefits and limitations of vaccines in preventing and control of infectious and non-infectious diseases thereby enhancing the quality and longevity of life.Vaccines 2017 mainly showcases comprehensive approaches in Vaccines and research, virology. vaccine conference includes Plenary lectures, Keynote lectures and short courses by eminent personalities from around the world in addition to contributed papers both oral and poster presentations
Kontakt
James Martin;     Tel.: [1-302-231-6959];     Email: Vaccines@madrige.com
Themen
Vaccines, virology, Infectious and non infectious diseases, Therapeutic Medicines
Verwandte Fachgebiete
25.
 
12th Annual Biomarkers Congress
ID
839687
Termin
21. Feb 2017 - 22. Feb 2017
Ort
Manchester, Großbritannien
Zusammenfassung
Oxford Global is proud to present its 12th Annual Biomarkers Congress taking place on the 21-22 February 2017 in Manchester. Our renowned congress will bring together over 300 attendees, speakers and vendor companies from pharmaceutical and biotechnology companies as well as academia.

In line with the current industry trends, the flagship event this year focuses on the discovery, development and clinical development of biomarkers in Autoimmune, Immuno-oncology, Neuroscience, Oncology as well as Cardiovascular, Rheumatology, COPD, Rare Diseases and Microbiome. Our expert speakers will also cover innovations in Biomarker research such as imaging biomarkers and assay development, big data challenges in biomarker research, new advances in biomarker technologies and platforms; insights into the human proteome atlas, population genetics, systems biology and their implications in Biomarker development. Do not miss out on gaining insights on the role of biomarkers in clinical development, clinical trials and clinical diagnostics.

Kontakt
Danielle Dalby;     Tel.: [+44 1865248455];     Email: d.dalby@oxfordglobal.co.uk
Themen
Clinical development, clinical trials, clinical diagnostics, innovative biology, microRNA’s, CTCs, liquid biopsies and free circulating RNA & DNA.
Verwandte Fachgebiete
26.
 
DDRI — 3rd Drug Discovery Re-Invented (Emerging Role of Biotechs, Academics and Non-Profits)
ID
842962
Termin
21. Feb 2017 - 24. Feb 2017
Ort
Cancun, Mexiko
Kontakt
Jack Peters;     Tel.: [01638 724137];     Email: jack@fusion-conferences.com
Themen
drugs, drug, drug discovery, pharma, pharmacology, research, pipelines, government, academic, non-profits, biotech, pharmaceutical, innovation, natural products, drug development, structure, modeling, approaches
27.
 
2nd Annual Lyotalk 2017 Asia — Pacific Largest conference in Freeze drying / Lyophilization
ID
852224
Termin
23. Feb 2017 - 24. Feb 2017
Ort
HYDERABAD, Indien
Zusammenfassung
The event covers a wide spectrum from formulation, Development, Production, manufacturing and regulatory affairs topics such formulation strategies, Scale-up, cycle development & optimization, Regulatory compliance, Quality by Design (QbD) , PAT process design, Ice Nucleation, Case studies & troubleshooting, New developments in freeze drying, Process development for generics, proteins, biologics and vaccines.
Kontakt
Linda Clark;     Tel.: [+912265344333];     Email: linda.clark@biotrains.com
Themen
The main topics will include • Formulation strategies • Scale-up, cycle development & optimization • Regulatory compliance • Quality by Design (QbD) • PAT process design, • Ice Nucleation • Case studies & troubleshooting • New developments in freeze drying • Process development for generics, proteins, biologics and vaccines.
28.
 
Frontiers in Cancer Immunotherapy
ID
824414
Termin
27. Feb 2017 - 28. Feb 2017
Ort
New York, NY, Vereinigte Staaten
Zusammenfassung
This 2-day scientific symposium will explore emerging findings in basic science, translational research, and clinical studies to improve immunotherapeutic approaches in cancer treatment. The event will convene basic, preclinical, and clinical researchers active in the field of cancer immunotherapy, alongside industry representatives and government stakeholders. Dr. James Allison, Executive Director of the Immunotherapy Platform at the University of Texas MD Anderson Cancer Center and a pioneer in the field of cancer immunotherapy, will commence the conference with a Keynote Address. Plenary speakers will present on an array of topics, including: the evaluation of combination therapy strategies to improve clinical benefit; the development of immune-monitoring strategies for the identification of relevant prognostic and predictive biomarkers; the development of strategies to overcome immune tolerance; and the incorporation of genomics into immunotherapeutic research and clinical trials.
Themen
Immunotherapy, Oncology, Immunology, Therapeutics, Clinical Trials, Vaccines, Diagnostics, Biomarkers, Genomics, Epigenomics, Epigenetics, Drug Discovery, Cancer
Verwandte Fachgebiete
29.
 
Disposable Solutions for Biomanufacturing
ID
859604
Termin
27. Feb 2017 - 01. Mär 2017
Ort
München, Deutschland
Zusammenfassung
By 2021 the knowledge and application of Single Use Systems will equal and even exceed that of Stainless Steel today. Where Disposable products and Single Use Technologies are becoming more widely used that ever before, this revolution has led to more questions than answers. In 2017, the 9th Annual event will bring you presentations from the main regulatory organisations plus panel discussions and case studies covering all aspects of disposables. Hear how to tackle all challenges from Particulates, Extractables and Leachables, System integrity, Implementation and more. This is the ONLY event that focuses on Single Use Technologies in biomanufacturing. For all your single use system questions, Disposable Solutions for Biomanufacturing Europe 2017 has the answers!
Kontakt
Rumina Akther;     Tel.: [+44 (0)207 036 1300];     Email: enquire@iqpc.co.uk
Themen
Single use systems, SUS, disposables, bioreactors, standardization, CMO, Good Manufacturing Practice, GMP facility, extractables and leachables, BPOG, BPSA
30.
 
Chemical Development & Scale-Up in the Fine Chemical & Pharmaceutical Industries
ID
858633
Termin
01. Mär 2017 - 03. Mär 2017
Ort
Pasadena, California, Vereinigte Staaten
31.
 
Seminar on the DHF, Technical File and Design Dossier - Similarities, Differences and the Future
ID
857623
Termin
02. Mär 2017 - 03. Mär 2017
Ort
Las Vegas, NV, Vereinigte Staaten
Kontakt
Event Manager;     Tel.: [(800) 447-9407];     Email: support@globalcompliancepanel.com
Themen
The Design History File, Device History Record, The Device Master Record, EU’s Medical Device Directive, Technical File Design Dossier, U.S. FDA’s DHF, FDA Compliance, FDA Regulations, Risk Analysis, Risk Management
32.
 
Keystone Symposia - Kinases: Next-Generation Insights and Approaches
ID
825322
Termin
05. Mär 2017 - 09. Mär 2017
Ort
Breckenridge, Colorado, Vereinigte Staaten
Zusammenfassung
Decades of both basic and applied research have unequivocally established the importance the kinase family of phosphotransferase enzymes in virtually every aspect of organismal homeostasis. From the initial characterization of ATP-dependent phosphorylation in the liver by Gene Kennedy in 1954, our understanding of the family has grown from the diverse perspectives of enzymology, biochemistry, biophysics, structural biology, genetics, cellular biology, pharmacology and physiology. Importantly, these advancements have yielded transformative therapeutic approaches to disease, most notably in the field of cancer where kinase inhibition is helping to fulfill the promise of precision medicine. Yet even today, our perspectives on the complexity of this class of enzymes continues to evolve, and many of the most exciting advancements in the field are being made by applying modern-day insights and technological approaches to the diverse roles the enzymes can play in health and human disease. This meeting will be devoted to exploring this innovative leading edge of kinase research, and will bring together leading researchers from academic, clinical and pharmaceutical settings to explore and define the new horizons in the field of kinase biology.
Kontakt
Tel.: [1 800-253-0685];     Email: info@keystonesymposia.org
Themen
Kinases, Drug Discovery, Kinase Signaling, Kinase Inhibitor
33.
 
BB17 — 3rd Biologics & Biosimilars Congress
ID
855077
Termin
06. Mär 2017 - 07. Mär 2017
Ort
Berlin, Deutschland
Zusammenfassung
This internationally respected congress is the networking meeting for those working in all areas of protein, antibody & biosimilar research. Executive panels and roundtables will foster discussion on the direction of the field, and the approaches required to ensure that the industry continues to flourish.
Kontakt
Jane Williams;     Tel.: [01865 849841];     Email: jane@globalengage.co.uk
Themen
Life Sciences/Biology, Health Sciences, Pharma
Verwandte Fachgebiete
34.
 
Pharmacodynamics, Biomarkers and Personalised Therapy
ID
828849
Termin
06. Mär 2017 - 10. Mär 2017
Ort
Oxford, Großbritannien
Zusammenfassung
The Pharmacodynamics, Biomarkers and Personalised Therapy course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the week will be led by Dr Elaine Johnstone, Senior Research Fellow at the University of Oxford, and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists, as well as a practical visit to one of Oxford's research laboratories.
Kontakt
Course Administrator;     Tel.: [+44(0)1865 286955];     Email: expther@conted.ox.ac.uk
35.
 
Recunnect Ltd — 3rd Anti-Counterfeiting Pharma Conference 2017
ID
870592
Termin
07. Mär 2017 - 08. Mär 2017
Ort
London, Großbritannien
Zusammenfassung
We welcome you to be a part of Recunnect’s 3nd Anti-Counterfeiting Pharma Conference 2017 showcasing the anti-counterfeiting strategies for a better informed decision making. The aim is to foster discussion on how to tackle counterfeiting and improve patient safety. Gain the best insight into the most pressing challenges through practical advice on streamlining procedures and practices in the industry.
Kontakt
Sarika Sareen;     Tel.: [2071129183];     Email: marketing@recunnect.net
Themen
Drug, pharma, health, medicines,
36.
 
Pharmaceutica 2017 — 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems
ID
833066
Termin
13. Mär 2017 - 15. Mär 2017
Ort
London, Großbritannien
Zusammenfassung
Pharmaceutica 2017 provides the perfect platform for just this as an interactive and engaging 3-day event: unique in format, content, networking and engagement. The event brings together truly innovative thinkers who are leading the way through trialing new disruptive solutions and rethinking the conventional formulation and delivery mind-set and will help you to better understand how to develop the right formulation and delivery strategy with a strong scientific, clinical and commercial mind set and how innovative scientific techniques, emerging technologies and innovative devices can transform formulation and drug delivery.
Kontakt
Renaldo Howell;     Tel.: [+1 702 508 5200];     Email: renaldohowell179@gmail.com
Themen
Pharmaceutics, Drug Delivery, Targeted Drug Delivery, Formulation, Pharmaceutical nanotechnology, nanomedicine, smart drug delivery
37.
 
Health Economics for Non-Health-Economists
ID
834429
Termin
16. Mär 2017 - 17. Mär 2017
Ort
Brüssel, Belgien
Zusammenfassung
Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
38.
 
2nd Personalized Medicine Conference
ID
853054
Termin
17. Mär 2017 - 20. Mär 2017
Ort
Cancun, Großbritannien
Zusammenfassung
Join us for the 2nd Personalized Medicine conference taking place from 17-20 March 2017 in Cancun, Mexico to discuss to discuss precision diagnostics, cancer genomics, biomarkers, computational imaging, bioinformatics and data analytics/big data. The personalized medicine space has been defined by recent regulatory approvals of targeted therapeutics in oncology and co-developed diagnostics used in patient selection. However, a broader view of personalized medicine encompasses other disease areas, newer therapeutic regimens, new therapeutic platforms and broad computational approaches. This conference will weave together many of these new approaches and their relevance to personalized medicine.
Kontakt
Laura Trundle;     Tel.: [+44 (0) 1638724137];     Email: laura@fusion-conferences.com
Themen
precision diagnostics, cancer genomics, biomarkers, computational imaging, bioinformatics and data analytics/big data.
Verwandte Fachgebiete
39.
 
Keystone Symposia - Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity
ID
825202
Termin
19. Mär 2017 - 22. Mär 2017
Ort
Tahoe City, California, Vereinigte Staaten
Zusammenfassung
There are fundamental aspects of metabolic homeostasis that are regulated differently in males and females, and influence both the development of diabetes and obesity and the response to pharmacological intervention. Still, most preclinical researchers avoid studying female rodents due to the added complexity of research plans. The consequence is the generation of data that risks being relevant to only half of the population. This is a timely moment to study sex differences in diseases as NIH leadership has asked scientists to consider sex as a biological variable in preclinical research, to ensure that women get the same benefit of medical research as men. The goal of this meeting is to fill a need in the scientific community by connecting interdisciplinary groups of scientists who normally would not have an opportunity to interact. This group includes investigators studying sex differences, the role of sex hormones, the systems biology of sex and the genetic contribution of sex chromosomes to metabolic homeostasis and diseases. Leaders of the pharmaceutical industry will present their views on sex-specific drug discovery. The meeting is expected to generate new knowledge and ideas on the importance of gender biology and medicine from a molecular standpoint to the population level, and to provide the methods to study them. It is intended to be a catalyst of a process that will lead to gender-specific treatments of metabolic diseases.
Kontakt
Tel.: [1 800-253-0685];     Email: info@keystonesymposia.org
Themen
sex, gender, metabolic homeostasis, diabetes, obesity, sex differences, estrogens, androgen, drug design, gender-specific medicine, metabolomics, genetics
Verwandte Fachgebiete
40.
 
Keystone Symposia - Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology
ID
825285
Termin
19. Mär 2017 - 23. Mär 2017
Ort
Whistler, British Columbia, Kanada
Zusammenfassung
The fields of cancer immunology and immunotherapy continue to make great strides in providing both a comprehensive understanding of the basic mechanisms underlying tumor-immune system interactions and applying this knowledge to the development of effective immune-based cancer therapies. This Keystone Symposia meeting is organized to highlight recent insights into the complex roles of immune components and pathways in controlling or alternatively promoting cancer and to showcase recent uses of cancer vaccines, checkpoint blocking strategies, adoptive cell therapies and cellular engineering approaches, either as mono- or combinatorial therapies, that have resulted in durable, effective and safe therapeutic responses to an increasing number of cancer patients. Part of the meeting will also focus on new, developing technologies that are likely to expand our capacity to monitor the effects of cancer immunotherapy with a precision, refinement and at a level that has not been possible in the past.
Kontakt
Tel.: [1 800-253-0685];     Email: info@keystonesymposia.org
Themen
cancer immunology, cancer immunotherapy, immunosuppressive cells, tumor microenvironment, immune checkpoints, combinatorial approaches, cancer vaccines, inflammation, cellular engineering, nex-gen technologies
Verwandte Fachgebiete
41.
 
ITOC4 — 4th ImmunoTherapy of Cancer Conference
ID
848908
Termin
20. Mär 2017 - 22. Mär 2017
Ort
Prag, Tschechische Republik
Zusammenfassung
The ITOC series of conferences is the premier meeting for education, scientific exchange and networking within cancer immunotherapy. The fourth edition (ITOC4) will take place on Prague, Czech Republic, from 20 to 22 March 2017. It aims at providing a forum for all professionals working in immunotherapy to discuss early clinical drug development and address the unique challenges of translational research. The programme will focus on the latest challenges and innovations with a special emphasis on combination therapy, immuno-monitoring and biomarker development.
Kontakt
Catherine Tomek (Congress Office);     Tel.: [+431405138318];     Email: itoc@medacad.org
Themen
Preclinical models, Co-stimulatory agonists and co-inhibitory antagonists, Immunogenomics, Therapeutic modulation of immune checkpoints, Combination therapy, Anti-cancer vaccines, Engineered T-cell therapy, Monitoring of immunotherapy
Verwandte Fachgebiete
42.
 
8th Annual Biotherapeutics Analytical Summit
ID
829761
Termin
20. Mär 2017 - 23. Mär 2017
Ort
Bethesda, Vereinigte Staaten
Zusammenfassung
Today’s complex biologics formats and ever increasing regulatory demands necessitates that companies come up with the most efficient, accurate and robust analytical methods to characterize a molecule; find the most effective tools to assess the molecule’s physico-chemical properties to optimize its druggability and developability, and to ensure that the end product is consistently safe and efficacious when comparing between batches or between biosimilars and innovators. When it comes to batch-to-batch variation, as the saying goes, “process is the product” – process analytics and quality control are thus of biggest concern to manufacturers and regulators alike.
Kontakt
Bethany Gray;     Tel.: [781-972-5400];     Email: chi@healthtech.com
43.
 
Chemical Development & Scale-Up in the Fine Chemical and Pharmaceutical Industries
ID
858708
Termin
21. Mär 2017 - 23. Mär 2017
Ort
Nice , Frankreich
44.
 
CMC Documentation & Post-Approval Changes/Variations
ID
854510
Termin
22. Mär 2017 - 23. Mär 2017
Ort
Frankfurt, NH Frankfurt Niederrad, Deutschland
Zusammenfassung
Do you work in regulatory affairs/CMC or quality assurance? Then you shouldn’t miss out on this event. This conference will address very practical questions and provide strategic information on future CMC trends. Join the in-depth discussion on new developments, including: requirements for drug substance and drug product, elemental impurities and stability, ASMF worksharing, GMP inspection and QP declaration, quality documentation of IMPs, quality risk management, management of post-approval CMC changes and much more.
Kontakt
Laura Vogelmann;     Tel.: [+49 6221 500-655];     Email: l.vogelmann@forum-institut.de
Themen
quality management, regulatory affairs, vigilance, drug substance and drug product in Module 3, how to implement ICH Q3D?, ASMF worksharing, QP declaration and GMP inspection, post-approval change management, CMC part of the IMPD
45.
 
CSS 2017 — Cool Supply System & Solutions 400+ 6th Annual Meeting 2017
ID
854180
Termin
23. Mär 2017 - 24. Mär 2017
Ort
Brüssel, Belgien
Zusammenfassung
Over 400 attendees at the GDP Brussels Cool Chain conference, 6th annual meeting time and temperature pharma controlled logistics.
Kontakt
Jessica Dobson;     Tel.: [+44 (0) 207 096 1152];     Email: Jessica.dosbson@businessdialogue.net
Themen
time and temperature, drug sensitive logistics, thermal packaging passive active, pharmaceutical logistics, logistics in pharmaceutical industry, reverse logistics in pharmaceutical industry, pharma distribution, pharma transport, cool chain logistics, European Cool chain conference 2017 Frankfurt Cool chain conference, IQPC Arena Cool chain conference, Brussels Cool Chain 2017, CSS 2017, Pharmaceutical supply chain conference, Drug Distribution, Last mile Movianto, Temperature controlled shipment, Pharma shippers Validation, Transport Pharma validation, Pharma logistics Brussels Airport, IATA CEIV Pharma Handling Validate, Good Distribution Practice Event, Pharma EU GDP conference, GDP quality system management, management review and monitoring of medicinal logistics, Pharma logistics quality risk management, the role of qualified person, validation of containers, qualification of storage or thermal mapping, Pharma 3pl, falsified medicinal products, drug integrity, Cool Chain Europe 2017
46.
 
Keystone Symposia - HIV Vaccines
ID
825181
Termin
26. Mär 2017 - 30. Mär 2017
Ort
Steamboat Springs, Colorado, Vereinigte Staaten
Zusammenfassung
Despite great progress in preventing and treating HIV, new infections continue to plague communities around the world, and the need for an HIV vaccine is as urgent as ever. Several large cohorts of HIV-infected individuals have enabled tremendous advances over the past five years in understanding immune responses to natural HIV infection. These advances have included the isolation of broad and potent anti-HIV antibodies, defining their developmental pathways, the generation of native-like Env trimers for immunization, and high-resolution structures of the envelope glycoprotein in complex with bnAbs. By 2017, many of these discoveries will have enabled new concepts to transition into human clinical trials, including passive monoclonal antibody therapy and novel immunization approaches. These platforms, incorporating improved technology for monitoring immune responses, will drive major advances in the vaccine field. This HIV Vaccines meeting will present the latest results from human clinical studies, along with the cutting-edge basic science behind such trials to highlight approaches that may lead to an HIV vaccine, and also reveal the molecular underpinnings of B and T cell-mediated immunity.
Kontakt
Tel.: [1 800-253-0685];     Email: info@keystonesymposia.org
Themen
HIV Vaccines, HIV, natural infection, transmission biology, immunogen platforms, b-cells, t-cells,
Verwandte Fachgebiete
47.
 
Drug Discovery 2017 — Drug Discovery 2017
ID
853316
Termin
27. Mär 2017 - 28. Mär 2017
Ort
London, Großbritannien
Zusammenfassung
The conference aims to bridge the gaps in approval for drug discovery and development by discussing the latest scientific breakthroughs, exploring novel technologies and approaches that can be used to overcome drug development challenges. Highlights include: discussions on the use of CRISPR/Cas9 Technology in target discovery, hit finding and translational studies; optimising the success of phenotyping screening; exploring whether translational medicine is capable of increasing success rate in pharma; insights into receptor activation from agonist and antagonist structures; and applications of enabling chemistry technology to the acceleration of the drug discovery process. Speakers include Sanofi, Takeda, AstraZeneca, Merck Serono, Novartis, AbbVie, GSK, Johnson & Johnson, UCB Pharma, Eli Lilly & Co and more. Register at http://www.drug-discovery.co.uk/coms
Kontakt
Honey de Gracia;     Email: hdegracia@smi-online.co.uk
Themen
drug discovery, drug development, stem cells, precise-genome editing, CRISPR/Cas9, phenotypic screening, translational medicine, receptor activation, agonist structures, drug design, computer aided drug design, fragment based drug design, SBDD, FBDD, CADD
48.
 
Training — Validation & Transfer of Methods for Biopharmaceutical Analysis
ID
864021
Termin
29. Mär 2017 - 31. Mär 2017
Ort
London, Großbritannien
49.
 
ICBMB 2017 International Conference on Biochemistry and Molecular Biology 3-5 April 2017, Munich, Germany
ID
853128
Termin
03. Apr 2017 - 05. Apr 2017
Ort
München, Deutschland
Kontakt
Andrea Berg;     Tel.: [adeo.office@gmail.com];     Email: adeo.office@gmail.com
Themen
biology, biochemistry, molecular biology
50.
 
Practical Approaches to Quality by Design (QbD) for Pharmaceutical Process Research, Development and Manufacturing
ID
858663
Termin
04. Apr 2017 - 06. Apr 2017
Ort
Verona, Italien
51.
 
MESMAP-3 — The Third Mediterranean Symposium on Medicinal and Aromatic Plants
ID
811603
Termin
13. Apr 2017 - 16. Apr 2017
Ort
Girne (Kyrenia), Cyprus, Türkei
Verwandte Fachgebiete
52.
 
Pharma Tech 2017 — International Conference and Exhibition on Pharmaceutical Development and Technology
ID
828953
Termin
24. Apr 2017 - 26. Apr 2017
Ort
Dubai, Vereinigte Arabische Emirate
Zusammenfassung
ConferenceSeries LLC is a renowned organization that organizes highly notable pharmaceutical conferences and healthcare conferences throughout the globe. ConferenceSeries LLC invites all the participants from all over the world to attend “International Conference and Exhibition on Pharmaceutical Development and Technology ”during April 24-26, 2017 Dubai, UAE.This includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Pharma Tech 2017 is a latest technological platform to aid efficient drug discovery and development. These platforms range from vast chemical libraries, ultra-high throughput screening and huge genetic databases in discovery, to predictive toxicology platforms and even deep-seated knowledge of particular therapeutic areas in development. New research platforms designed to help its teams of investigators focus on a set of key strategic initiatives that will help guide their multibillion-dollar drug development program to advance new medicines that can get ahead of a disease and prevent it from taking a toll.
Kontakt
Mythrei Syria;     Tel.: [+1-702-508-5200];     Email: pharmatech@pharmaceuticalconferences.com
Themen
Pharmaceutical Technology, Pharmaceutical Technology Conferences, Pharma Tech Meetings, Pharma Tech Symposiums, Pharma Tech Exhibitions, Pharma Tech 2017 Conferences, Pharma Tech Conferences Dubai, Pharma Tech meetings USA, Pharma Tech Conferences euro
Verwandte Fachgebiete
53.
 
Pharma Strategic Alliance Management — 7th Annual Strategic Alliance Management for Pharma
ID
871394
Termin
24. Apr 2017 - 26. Apr 2017
Ort
London, Großbritannien
Zusammenfassung
This marcus evans conference goes back to the fundamentals: how to structure the Alliance management internally, what are the responsibilities and roles of the Alliance function. With various types of collaborations, complex projects, it’s important for Alliance Management to be structured and to have the right tools available. We will also point out the value creation in the company and how evaluating alliances by measuring progress, bringing KPI and performance tools in the process. Structuring alliances is also to count on governance body and look at relations with steering committees, legal entities and contracts to effectively run alliances along their life cycle. The delegates will have the possibility to discuss, exchange and compare their methods but also meet various stakeholders of the life science panorama.
Kontakt
Constandinos Vinall;     Tel.: [+357 22 849 380];     Email: ConstandinosV@marcusevanscy.com
Themen
Implement the best practices in managing alliances, Improve alliance capabilities on the full alliances portfolio, Define and document common understanding and expectations with partners, Develop a set of tools to measure performance and objectives’ alignment, Choose the right partner according to the strategy and needs, Set mutual trust and keep the relationship in good conditions, Expand Alliance management framework across the organisation, Cope with unsuccessful partnerships and termination processes
54.
 
Corvus Global Events — Digi-tech Pharma 2017
ID
850905
Termin
25. Apr 2017 - 26. Apr 2017
Ort
London, Großbritannien
Zusammenfassung
Digital Pharma World 2017, will provide a platform to all its participants an opportunity to interact, share and discuss the digitalization of Pharma industry. It will allow its participants to discuss the various challenges faced, new strategies, case studies and use of innovative ideas in the field of digital pharma. Also, to stay updated on the latest trends in digital, social media and mobile strategies required the overcome the obstructions in the transformation. This conference will allow IT leaders to share their technologies and strategies to help the pharma industries. The conference will offer opportunities to encourage partnerships and collaborations
Kontakt
Fazmina Fajjuu;     Tel.: [+44 (0) 207 096 0786];     Email: fazmina@corvusglobalevents.com
Themen
Key Highlights of the conference: • Digitally enabled business models • Big data analytics and pharma • Internet of things and pharma • Translational Informatics • Policy changes required for ensuring smooth transition • Ensuring regulatory compliance during the transformation • Digital marketing trends • Integrating Multichannel marketing and closed loop marketing • Digitalization of R& D using Big Data and IoT • New smart devices in manufacturing and supply chain • Clinical trials and digital world • Data management • Tools and strategies to engage with HCPs and patients and to win their confidence • Encouraging a customer–centric approach at all levels • Unrealized innovative potentials of digital era that pharma needs to focus on . Attendees includes VPs, GMs, Directors, Heads and Managers of • Pharma sales and Marketing • E-marketing • Digital innovative strategic planning • Regulatory and pharmacovigilance • IT consultants • Clinical trials and data management • Translational informatics • Data storage and analysis • Contract outsourcing service providers • Multi-channel Management • Health care professionals • Health IT professionals
55.
 
PFS East Coast — Pre-Filled Syringes East Coast
ID
854619
Termin
26. Apr 2017 - 27. Apr 2017
Ort
Boston, Großbritannien
Zusammenfassung
Building on the success of previous sell-out shows, SMi Group is delighted to announce the return of the 4th annual conference and exhibition: Pre-Filled Syringes - East Coast, taking place on April 26th – 27th 2017 in Boston, Massachusetts, USA. Through a combination of powerful keynote addresses, topical debate and interactive workshops, Pre-Filled Syringes East Coast will once again play host to an audience of senior scientists, device manufacturers and PFS market professionals, providing a unique platform to discuss the latest innovations and developments in pre-filled syringes; as well as hone in on industry challenges and regulatory compliance. Featured speakers include AbbVie, Shire, Amgen, Eli Lilly, Allergan, Janssen, Merck and more!
Kontakt
Teri Arri;     Tel.: [2078276000];     Email: tarri@smi-online.co.uk
Themen
prefilled syringe, pre-filled syringe, autoinjector, human factors, device development, innovation, strategy, extractables, leachables, patient safety, compliance, biosimilar, parenteral, packaging, combination products, lyophilisation, freeze drying, injectable, injectable devices, syringe, extractables and leachables, E&L, PFS, drug device, drug delivery, combination products, sterilization, needle, component, glass syringe, cop syringe, container, formulation, device development, human factors, manufacturing, device technology, medical device, parenteral drug, plastic, qbd, drug delivery
Verwandte Fachgebiete
56.
 
Training — Validation & Transfer of Methods for Biopharmaceutical Analysis
ID
864053
Termin
26. Apr 2017 - 28. Apr 2017
Ort
Berlin, Deutschland
57.
 
Keystone Symposia - Modeling Viral Infections and Immunity
ID
825364
Termin
01. Mai 2017 - 04. Mai 2017
Ort
Estes Park, Colorado, Vereinigte Staaten
Zusammenfassung
Viral infection modeling has provided insights into the pathogenesis and treatment of HIV, HCV, HSV-2, CMV and other viruses. It has had impact in revealing the lifespan of infected cells, how rapidly virus is produced and cleared from the circulation, and the means for evaluating the effectiveness of antiviral treatments. HIV remains a global health threat and there is great interest in revealing features of the main HIV reservoir, latently infected cells and mechanisms of reducing the size of this reservoir by pharmacological means. Other important gaps in knowledge revolve around the cell-mediated and humoral immune responses to HIV, important for generating vaccines and broadly neutralizing antibodies as therapeutics, topics that will be discussed. Further, viral infections generally occur in tissues and thus the meeting will discuss imaging techniques and methods of modeling and analyzing spatial infection data, the role of tissue-resident memory cells, and important features of immune regulation, such as immune exhaustion, cytokine signaling between cells, and viral subversion of innate responses and escape from adaptive responses. The meeting will highlight what we believe are significant hurdles to curing viral infections and will bring together experimental virologists, physician scientists and modelers of various types and experience, groups that do not normally meet. It should foster new collaborations between experimentalists and theoreticians, and between theoreticians working on different viral infections or different aspects of viral infections, as well as help young scientists formulate new research directions and make connections with established senior scientists.
Kontakt
Tel.: [1 800-253-0685];     Email: info@keystonesymposia.org
Themen
modeling viral infections, immunity, viral infection, Modeling Immune Regulation, HIV, Modeling Cellular Immune Responses, Spatial Aspects of Infection
Verwandte Fachgebiete
58.
 
Training — Validation & Transfer of Methods for Pharmaceutical Analysis
ID
864074
Termin
03. Mai 2017 - 05. Mai 2017
Ort
Dublin , Irland
59.
 
3rd Annual Formulation & Drug Delivery Congress
ID
859596
Termin
08. Mai 2017 - 09. Mai 2017
Ort
London, Großbritannien
Zusammenfassung
Oxford Global are proud to present our 2017 3rd Annual Formulation & Drug Delivery Congress, taking place on 8 – 9 May 2017 in May in London, UK. Over 300 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions will have the opportunity to discuss over 40 presentations and case studies focused on the key issues in large molecule and small molecule drug formulation and drug delivery. Including 4 interactive streams: Large Molecule Drug Formulation; Small Molecule Drug Delivery; Small Molecule Drug Formulation and Large Molecule Drug Delivery.
Kontakt
Guillaume Alonso;     Tel.: [+44 (0) 1865 248 455];     Email: g.alonso@oxfordglobal.co.uk
Themen
drug delivery, drug formulation, small molecule, large molecule
Verwandte Fachgebiete
60.
 
Adverse Drug Reactions, Drug Interactions and Pharmacovigilance
ID
828848
Termin
08. Mai 2017 - 12. Mai 2017
Ort
Oxford, Großbritannien
Zusammenfassung
The Adverse Drug Reactions, Drug Interactions and Pharmacovigilance course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the teaching will be led by Dr Michael Theodorakis, Radcliffe Department of Medicine, University of Oxford, and will feature face-to-face lectures and tutorials from some of the country's leading clinicians and scientists.
Kontakt
Course Administrator;     Tel.: [+44(0)1865 286955];     Email: expther@conted.ox.ac.uk
61.
 
The Health Technology Assessment Course - Trends & Opportunities in Europe
ID
834291
Beginn
09. Mai 2017
Ort
Brüssel, Belgien
Zusammenfassung
Understand what HTA really means, the different types of HTAs across the EU and what can be expected from it – Learn the optimal HTA process and which criteria for assessment should be applied – Discover multiple solutions for optimising the quality of the evidence.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
62.
 
E&L USA 2017 — Extractables & Leachables USA 2017
ID
854305
Termin
09. Mai 2017 - 11. Mai 2017
Ort
Falls Church, VA, Vereinigte Staaten
Zusammenfassung
Extractables and leachables examination is continuously growing in importance. Given the current scruitny paid by governing bodies including the FDA and EMEA, understanding the best practice and guidelines to carry out extractables and leachables studies is imperative in order to eliminate risk and potential development delays.
Kontakt
Emma Nweton;     Tel.: [+44 (0) 1372 802016];     Email: enewton@smithers.com
Themen
extractables, leachables, analytical chemistry, pharmaceuticals, drug development, drug delivery, regulations, quality assurance, single-use systems, risk assessments, packaging, drug packaging
63.
 
Orphan Drugs and Rare Diseases Europe 2017
ID
852698
Termin
15. Mai 2017 - 16. Mai 2017
Ort
Berlin, Deutschland
Zusammenfassung
SMi is proud to announce the return of their 6th annual Orphan Drugs event to Berlin on the 15th -16th May 2017! The global orphan drug market totaled nearly $123 billion in 2014 and will continue to grow to reach nearly $191 billion by 2019.* With such growth and innovation witnessed in this field now is the best time to discuss and strategize the best route to market.
Kontakt
Kyra Williams;     Email: kwilliams@smi-online.co.uk
Themen
Orphan Drugs, Rare Diseases, Market Access, Pricing and Reimbursement, Patient Recruitment
64.
 
Gavin Conferences — International Conference on Pharmaceutical Drugs
ID
848140
Termin
15. Mai 2017 - 17. Mai 2017
Ort
Dubai, Vereinigte Arabische Emirate
Zusammenfassung
Gavin Conferences invites participants from all over the world to attend “International Conference on Pharmaceutical Drugs” to be held on May 15-17, 2017 at Dubai, UAE. The conference is organized with the theme “Bridging the gap between Drugs and Disease Prevention” which includes keynote presentations from world class scientists and researchers, Oral talks, Poster presentations, B2B meetings and Exhibitions. World-renowned speakers, the most recent techniques and updates in the field of Pharmaceutics are hallmarks of this conference.
Kontakt
Daniel;     Tel.: [6303970234];     Email: danielgavin456@gmail.com
Themen
Pharmaceutical Drug Development,  Drug Formulation, Evaluation, Drug Discovery, Drug Designing, Drug Delivery Systems, New Manufacturing technologies, Pharmaceutical Industry, Adverse Drug Reactions, Pharmaceutical Business
65.
 
MENA Cold Chain — 4th Annual MENA Pharmaceutical Cold Chain Forum
ID
870085
Termin
16. Mai 2017 - 17. Mai 2017
Ort
Dubai, Vereinigte Arabische Emirate
Zusammenfassung
The MENA region continues to face its challenges as most temperature deviations occur during supply chain transportation. The pharmaceutical industry relies heavily on the airline industry for its speed and efficiency. Unfortunately, 57% of deviations happen at the airport premises. Temperature changes during transportation have been a serious threat to the integrity of the products. Shippers in the region are on a constant look out for service providers who can help them maintain the product integrity and efficacy during transportation.
Kontakt
MCI Dubai;     Tel.: [97143116300];     Email: conferences@mci-group.com
Themen
Pharmaceutical
66.
 
Principles of Pharma Market Access in Europe
ID
834283
Termin
16. Mai 2017 - 17. Mai 2017
Ort
Zürich, Schweiz
Zusammenfassung
Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
67.
 
Value Pricing for Market Access - The Fundamentals
ID
834344
Termin
18. Mai 2017 - 19. Mai 2017
Ort
Zürich, Schweiz
Zusammenfassung
Understand the language, the concepts and pricing research techniques in pharma – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
68.
 
HPAPI — Highly Potent Active Pharmaceutical Ingredients (HPAPI) 2017
ID
854610
Termin
22. Mai 2017 - 23. Mai 2017
Ort
London, Großbritannien
Zusammenfassung
The global market for Highly Potent Active Pharmaceutical Ingredients is currently on a growth fast track, largely driven by its major use in oncology for cancer treatment and more often in the form of ADCs. Over a quarter of drugs worldwide now contain HPAPIs, as they have proven to be more effective than other APIs. However, working with APIs high in potency and cytotoxicity comes with many regulations and requirements, and presents pharmaceutical companies with challenges such as handling, containment, cost and security questions. This conference will cover many important and in-demand aspects of the HPAPI industry, creating a networking platform for industry professionals and key players to share their knowledge and find innovative new solutions.
Kontakt
Kyra Williams;     Email: kwilliams@smi-online.co.uk
Themen
API- Active Pharmaceutical Ingredients, Cytoxic, Potency, HA - Health Agency, PDE - Permitted Daily Exposure, Cross Contamination, Compound, Scale Up
Verwandte Fachgebiete
69.
 
Biologistics World Korea 2017
ID
827208
Termin
23. Mai 2017 - 24. Mai 2017
Ort
Seoul, Republik Korea
Zusammenfassung
Biologistics World Korea is the MOST Targeted event in Korea that focuses on supply chain management and logistics for biologics and vaccines. Located in Singapore, the prime logistics hub of Korea, the programme promises to bring together key opinion leaders, rising players and market experts to discuss, debate and brainstorm on the most pertinent issues affecting Korea’s logistics network within a global context!
Kontakt
Andrew Darwitan;     Tel.: [+65 3109 0156];     Email: andrew.darwitan@imapac.com
70.
 
Learning and Memory: Cellular and Molecular Mechanisms
ID
857922
Termin
28. Mai 2017 - 04. Jun 2017
Ort
Siena, Italien
Zusammenfassung
Recent ground-breaking developments in neuroscience, such as optogenetics, in vivo 2-photon confocal microscopy, head mounted microscopes, powerful new developments in modeling, behavioral neuroscience approaches, and sophisticated brain imaging tools, have changed dramatically studies of memory. Most importantly, these developments have fostered interdisciplinary studies that led to integrated molecular, cellular, systems, cognitive and behavioral explanations of how memories are allocated, formed, consolidated, reconsolidated and retrieved. These studies have also led to mechanistic cross-disciplinary studies of memory disorders, which in some cases led to the development of targeted treatments that are changing how we imagine treating the considerable health burden associated with this large class of conditions.
Kontakt
Francesca Martini;     Tel.: [+39.0577.146.0003];     Email: info@nsas.it
Verwandte Fachgebiete
71.
 
18th Annual Drug Discovery Summit
ID
845334
Termin
12. Jun 2017 - 13. Jun 2017
Ort
Berlin, Deutschland
Zusammenfassung
This summit brings together over 250 key opinion leaders and senior industry experts in drug discovery, to discuss the latest innovative discovery strategies in different therapeutic areas as well as the most effective enabling technologies and solutions. Our co-located 5th Discovery Chemistry & Drug Design Congress provides an unprecedented opportunity to gain insights from key presenters of the computational chemistry, discovery chemistry and medicinal field.
Kontakt
Guillaume Alonso;     Tel.: [+44 (0) 1865 248 455];     Email: g.alonso@oxfordglobal.co.uk
Themen
drug discovery, screening, genomics, biotechnology, pharmaceutical, small molecule, large molecule, technologies
72.
 
Pharma Engineering 2017 — International Conference on Pharmaceutical and Biomedical Engineering
ID
852666
Termin
12. Jun 2017 - 13. Jun 2017
Ort
Taipei, Taiwan
Zusammenfassung
Conference Series LLC is a renowned organization that organizes highly notable conferences throughout the globe. Currently we are bringing forth “International Conference on Pharmaceutical and Biomedical Engineering” (Pharma Engineering 2017) scheduled to be held during June 12-13, 2017 at Taipei, Taiwan. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutical and Biomedical Engineering.
Kontakt
Diya Sharan;     Tel.: [7025085200];     Email: pharmaengineering@pharmaceuticalconferences.com
Themen
Pharmaceutical Engineering, Biomedical Engineering, Pharmaceutical Technology, Pharmaceutical Formulations, Drug delivery, Drug Discovery, Genetic Engineering, Tissue Engineering, Bio Imaging, Process Engineering, Pharmaceutical Process Technology Novel drug deliveryNanotechnology Engineering
73.
 
10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems
ID
831656
Termin
13. Jun 2017 - 15. Jun 2017
Ort
London, Großbritannien
Kontakt
Renaldo Hawell;     Email: renaldohowell179@gmail.com
Themen
Pharmaceutics/Formulation/Drug Delivery/Vaccine/Novel Drug Delivery
74.
 
Chemical Development & Scale-Up in the Fine Chemical and Pharmaceutical Industries
ID
858829
Termin
13. Jun 2017 - 15. Jun 2017
Ort
Edinburgh , Großbritannien
75.
 
Practical Approaches to Quality by Design (QbD) for Pharmaceutical Process Research, Development and Manufacturing
ID
858784
Termin
13. Jun 2017 - 15. Jun 2017
Ort
Chicago, Vereinigte Staaten
76.
 
Training — Validation & Transfer of Methods for Pharmaceutical Analysis
ID
864128
Termin
14. Jun 2017 - 16. Jun 2017
Ort
London, Großbritannien
77.
 
FASEB SRC — From Unfolded Proteins in the Endoplasmic Reticulum (ER) to Disease
ID
871000
Termin
18. Jun 2017 - 23. Jun 2017
Ort
Saxtons River, VT, Vereinigte Staaten
Zusammenfassung
This SRC focuses on the endoplasmic reticulum (ER) and its functions. The purpose of the meeting is to merge recent developments in molecular biology, cell biology, genetics, and physiology aimed at unraveling the complexities of secretory protein folding, ER stress pathways, lipid signaling, and ER membrane biology, and how failure of these processes lead to pathologies and disease. This SRC will include talks from outstanding scientists, both invited and selected from poster abstracts. The meeting is known for its active discussions, not only during the presentation session, but also during the free afternoons, and especially during the poster sessions. Posters will remain on display during most of the conference and a selection will be advertised in oral poster pitches. The venue, Vermont Academy, is excellently suited for the mingling of junior and established scientists, which will be strengthened by meet-the-speaker sessions that allow discussions of both career issues and science.
Kontakt
FASEB SRC Staff;     Tel.: [3016347010];     Email: src@faseb.org
Themen
biochemistry, Pharmacology
Verwandte Fachgebiete
78.
 
Health Economics for Non-Health-Economists
ID
834351
Termin
20. Jun 2017 - 21. Jun 2017
Ort
Brüssel, Belgien
Zusammenfassung
Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
79.
 
Antibodies & Complement: Effector Functions, Therapies & Technologies
ID
781813
Termin
20. Jun 2017 - 23. Jun 2017
Ort
Albufeira, Portugal
Zusammenfassung
The antibody response and the complement system are major effector arms of the immune system. Both have been involved in a plethora of pathological conditions – including autoimmunity, allergy, infections and cancer- and regulate, mainly through their receptors (FcR and CR respectively) cell activation, migration, survival but also metabolism. As the portfolio of antibody- and complement-effector function grow, high-end technological solutions are developed and novel therapeutic applications are proposed.

This Zing conference will focus attention on key advances in both fields with the aim at fostering discussions between antibody experts and complement experts.

Verwandte Fachgebiete
80.
 
16th Annual Medicinal & Pharmaceutical Sciences Congress (Med Pharma Congress)
ID
852314
Termin
03. Jul 2017 - 05. Jul 2017
Ort
Kuala Lumpur, Malaysia
Zusammenfassung
Conference Series LLC invites all the participants across the globe to attend 16th Annual Medicinal & Pharmaceutical Sciences Congress during July 3-5, 2017 in Kuala Lumpur, Malaysia which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Med Pharma Congress is a specially designed cluster Pharma conference. The main theme of this Pharma conferences is “Developing the Synergy between Pharmaceutics and Medicinal Chemistry to Deliver Better Drugs” which covers a wide range of critically important sessions.
Themen
Medicinal Chemistry • Pharmacology • Chromatographic Techniques for Drug Analysis • Synthetic Organic Chemistry • Bio Pharmaceuticals • Pharmacogenomics • Pharmacognosy and Phytochemistry • Pharmaceutical Toxicology • Industrial Pharmacy
Verwandte Fachgebiete
81.
 
How to do Research on Therapeutic Interventions: Protocol Preparation
ID
828809
Termin
03. Jul 2017 - 07. Jul 2017
Ort
Oxford, Großbritannien
Zusammenfassung
The How to do Research on Therapeutic Interventions: Protocol Preparation course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the teaching will be led by Dr Grant D Vallance, Information Manager at the Oxford University Hospitals NHS Trust, and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists.
Kontakt
Course Administrator;     Tel.: [+44(0)1865 286955];     Email: expther@conted.ox.ac.uk
82.
 
9th World Congress on BA/BE Studies and Biowaivers
ID
849796
Termin
17. Jul 2017 - 19. Jul 2017
Ort
Melbourne, Australien
Zusammenfassung
Bioequivalence Congress is a 3-day event offering the Exhibition, at venue to showcase the new and emerging technologies and have wider sessions involving Keynote presentation, Oral, YRF ( student presentation), poster, e-poster presentations. World-renowned speakers and eminent delegates across the globe attending the conference, to share their valuable presentation on the most recent and advanced techniques, developments, and the newest updates are the prominent features of the conference.
Kontakt
Daisy Pearl;     Tel.: [(702) 508-5200 Extn-8045];     Email: ba.beasia@pharmaceuticalconferences.org
Themen
drug research, generic drugs, bioequivalence, pharmacology, clinical pharmacology, bcs, biowaivers, pharmcodynamic studies, clinical trails, clinical research, FDA
83.
 
9th International Conference and Exhibition on Pharmacovigilance & Drug Safety
ID
869819
Termin
17. Jul 2017 - 19. Jul 2017
Ort
München, Vereinigte Staaten
Kontakt
programe cordinator;     Tel.: [702-508-5200];     Email: pharmacovigilance@pharmaceuticalconferences.org
Themen
Advanced Regulatory Compliance in Pharmacovigilance operations and innovations Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business
84.
 
NanoPharma 2017 — 13th International Conference and Exhibition on Pharmaceutical Nanotechnology
ID
852425
Termin
24. Jul 2017 - 25. Jul 2017
Ort
Rom, Italien
Zusammenfassung
Currently we are bringing forth “13th International Conference and Exhibition on Pharmaceutical Nanotechnology” (NanoPharma 2017) scheduled to be held during July 24-25, 2017 at Rome, Italy. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutical Nanotechnology and Drug delivery.
Kontakt
Angela Mathews;     Tel.: [7025085200];     Email: nanopharma@pharmaceuticalconferences.org
Themen
drug delivery, nanoparticles, nanodrugs, nanomedicines, nanopharmaceuticals, pharmaceutical nanotechnology, liposomes, neosomes, erythrosomes
Verwandte Fachgebiete
85.
 
Asia Pharma 2017 — 10th Asia-Pacific Pharma Congress
ID
827489
Termin
24. Jul 2017 - 26. Jul 2017
Ort
Melbourne, Australien
Zusammenfassung
Asia Pharma 2017 is a perfect platform for scientists, decision-makers and students to come together, compare findings, and discuss the science of the future. Share your research with an engaged audience of your peers from around the globe; learn from scientific trail blazers who are designing more sustainable processes; find out how Pharmaceutical innovations are inspiring new businesses and product lines. Pharmaceutical sciences focus on the physiology and chemistry controlling drug therapeutic action in modern medicine. Often confused with pharmacy practice, pharmaceutics is distinct in its research and development emphasis, contributing important technologies and scientific bases for drug delivery to patients. Over half of newly discovered drug candidates cannot be commercialized without further drug delivery and formulation assistance. Researchers trained in pharmaceutics integrate a broad working knowledge of diverse scientific disciplines: from fundamental studies of drug physiochemical properties and bioactive molecules to mechanisms of various physiological processes that impact drug delivery to specific biological sites of action and, therefore, their therapeutic effectiveness. Increasing awareness of the complexity of the drug delivery process in living systems means that researchers in pharmaceutics today must maintain breadth and depth in physical chemistry, physical organic chemistry, bioengineering, nanotechnology and the life sciences in order to solve research problems that require integration basic science concepts from multiple disciplines with medical applications.
Kontakt
Robert Brown;     Tel.: [17025085200];     Email: asiapharma@pharmaceuticalconferences.com
Themen
Regulatory Affairs, Intellectual Property Rights, Pharmacognosy and Phytochemistry, Advancements in Pharmaceutics, Trends in Nanotechnology, Industrial Pharmacy, Pharmacological Studies, Pharmaceutical Chemistry, Pharmaceutical Analysis, Pharmaceutical Microbiology, Pharmaceutical Biotechnology, Biochemistry and Molecular Biology, Clinical Pharmacy, Hospital Pharmacy, Pharmaceutical Care & Health Systems, Pharma Compliance.
86.
 
International Vaccines Congress
ID
857180
Termin
27. Jul 2017 - 28. Jul 2017
Ort
Chicago, Vereinigte Staaten
Zusammenfassung
PULSUS is the publisher of peer reviewed scientific, technical, and medical journals and magazines. Since establishment 1984, has been instrumental in healthcare and medical dissemination. PULSUS expanded with the support from scientific societies and open its arm to conduct global medical and healthcare meetings. With immense please and support, PULSUS is honored to announced it International Vaccines Congress, which will be going to held in Chicago, USA during July 27-28, 2017.
Kontakt
Annah Brwon;     Email: vaccinescongress@protonmail.com
Themen
vaccines Congress, Vaccines Conference 2017, Vaccines Conference USA
Verwandte Fachgebiete
87.
 
Pharmacology Studies 2017 — International Conference on Pharmacology & Toxicology Studies
ID
859551
Termin
07. Aug 2017 - 09. Aug 2017
Ort
Philadelphia, Vereinigte Staaten
Zusammenfassung
Scientific Synergy Conferences are delighted to welcome you all to the
Kontakt
Scientific Synergy;     Tel.: [+1-888-623-5051];     Email: pharmacology@scientificsynergy.com
Themen
Pharmacology Studies 2017, Pharmacology Conference, Toxicology Conference, Scientific Synergy USA, Pharmacology Conference Philadelphia, Pharmacology Congress USA, Clinical Pharmacology event, Drug Toxicology, Pharmacology Case Reports, Forensic Toxicology.
88.
 
Biosimilars Asia 2017 — 8th Asian Biosimilars Congress
ID
841101
Termin
14. Aug 2017 - 16. Aug 2017
Ort
Osaka, Japan
Zusammenfassung
Biosimilars Asia 2017 is a specially designed cluster conference. The main theme of the conference is
Kontakt
Victorya Jones;     Tel.: [7025085200];     Email: biosimilarsasia@pharmaceuticalconferences.com
Themen
biosimilars, biologics, biosimilars conference, biologics conferences, biosimilars events, Biologics events, biosimilars workshops
89.
 
Practical Approaches to Quality by Design (QbD) for Pharmaceutical Process Research, Development and Manufacturing
ID
858801
Termin
11. Sep 2017 - 13. Sep 2017
Ort
Clarion Hotel Prague, Tschechische Republik
90.
 
Formulation & Drug Delivery USA Congress
ID
871360
Termin
14. Sep 2017 - 15. Sep 2017
Ort
Boston, Vereinigte Staaten
Zusammenfassung
Oxford Global are proud to present our Formulation & Drug Delivery USA Congress, taking place on 14 – 15 September 2017 in Boston. Over 150 delegates representing leading pharmaceutical organisations, biotech companies and internationally renowned research & academic institutions will be present to discuss and network. Over 40 case studies and presentations focused on exploring regulatory guidelines of both large and small molecule formulations, future applications of protein and peptide formulations, recent advancements in nanoparticles as drug delivery systems, combination drug delivery devices and improving the bioavailability of compounds.
Kontakt
Guillaume Alonso;     Tel.: [+44 (0) 1865 248 455];     Email: g.alonso@oxfordglobal.co.uk
Themen
drug formulation, drug delivery, small molecules, large molecules
91.
 
Training — Validation & Transfer of Methods for Pharmaceutical Analysis
ID
864105
Termin
27. Sep 2017 - 29. Sep 2017
Ort
Berlin, Deutschland
92.
 
Principles of Pharma Market Access in Europe
ID
834315
Termin
03. Okt 2017 - 04. Okt 2017
Ort
Brüssel, Belgien
Zusammenfassung
Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
93.
 
Value Pricing for Market Access - The Fundamentals
ID
834398
Termin
05. Okt 2017 - 06. Okt 2017
Ort
Brüssel, Belgien
Zusammenfassung
Understand the language, the concepts and pricing research techniques in pharma – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
94.
 
Safety & Selectivity in the Scale-Up of Chemical Reactions
ID
858887
Termin
09. Okt 2017 - 10. Okt 2017
Ort
Lisbon , Portugal
95.
 
Scaling from Milligrams to 1-2kg: Making the First GMP Batch
ID
858831
Termin
09. Okt 2017 - 10. Okt 2017
Ort
Lisbon , Portugal
96.
 
Chemical Development & Scale-Up in the Fine Chemical and Pharmaceutical Industries
ID
858841
Termin
11. Okt 2017 - 13. Okt 2017
Ort
Lisbon , Portugal
97.
 
Health Economics for Non-Health-Economists
ID
834350
Termin
12. Okt 2017 - 13. Okt 2017
Ort
Zürich, Schweiz
Zusammenfassung
Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
98.
 
Training — Validation & Transfer of Methods for Biopharmaceutical Analysis
ID
864060
Termin
18. Okt 2017 - 20. Okt 2017
Ort
London, Großbritannien
99.
 
MedTechConf Sarajevo
ID
868355
Termin
19. Okt 2017 - 20. Okt 2017
Ort
Sarajevo, Bosnien und Herzegowina
Kontakt
Edina Musmulja;     Tel.: [+ 387 61 914 178];     Email: info@medtechconf.com
Themen
Regenerative Medicine & Biological Materials, Future Drugs, Three-dimensional Echocardiography, Neuroscience, Health Economics, Artificial Intelligence & New Technology Development, Future Healthcare Ecosystems & Medical Billing
100.
 
ICCP — 5th International Conference on Clinical Pharmacy
ID
858248
Termin
23. Okt 2017 - 24. Okt 2017
Ort
Florida, Vereinigte Staaten
Zusammenfassung
Clinical Pharmacy Conference aims to bring together leading academic scientists, researchers, and research scholars to exchange and share their experiences and research results about all aspects of Clinical Pharmacy. It also provides the disciplinary forum for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Clinical Pharmacy. All honorable authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers, and e-posters. Also, high-quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Clinical Pharmacy are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers, and e-posters that address themes and topics of the conference, including figures, tables, and references of novel research material. The conference abstracts and proceedings book and certificate of presentation will be distributed to the conference participants at the conference registration desk. In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of biomedical, pharmaceutical, and clinical sciences by providing a platform for critical analysis of new data, and to share latest cutting-edge research findings and results about all aspects of Clinical Pharmacy.
Kontakt
Victor Badoni;     Tel.: [7025085200 Ext: 8047];     Email: badonivictor@outlook.com
Themen
Pharma Conferences, Pharmacy Conferences, Clinical Pharmacy Conferneces, Pharmaceutical Conferences
101.
 
Practical Approaches to Quality by Design (QbD) for Pharmaceutical Process Research, Development and Manufacturing
ID
858928
Termin
31. Okt 2017 - 02. Nov 2017
Ort
Boston , Vereinigte Staaten
102.
 
Biomarkers congress 2017 — Annual World Congress on Biomarkers & Clinical Research
ID
867795
Termin
27. Nov 2017 - 28. Nov 2017
Ort
Atlanta, Vereinigte Staaten
Zusammenfassung
PULSUS brings in a new spin on conferences by presenting the latest scientific improvements in Biomarkers and its clinical researches. Listen to motivating keynotes from thought leaders, pioneers across the globe. Atlanta is all set for an amazing event as PULSUS proudly presents the “Annual World Congress on Biomarkers & Clinical Research” on November 27-28, 2017. PULSUS cordially welcome researchers, academicians, students and business professionals in the field of BIOMARKERS from around the world to participate in the upcoming BIOMARKERS CONGRESS 2017. The meeting for this year will revolve around the theme “Explore the latest Biomarkers development in health and clinical research” thus relaying the most cutting edge findings in the field of Biomarkers Research.
Kontakt
Rachel Mathews;     Email: america@cmesociety.com
Themen
Biomarkers Conference, Biomarkers Conference 2017, Biomarkers Conference December, Cancer Biomarkers, Cancer Conferences, Cancer Conferences 2017, Biomarkers Events, Biomarkers Society Conferences, Biomarkers Congress
Verwandte Fachgebiete
103.
 
Training — Validation & Transfer of Methods for Biopharmaceutical Analysis
ID
864114
Termin
27. Nov 2017 - 29. Nov 2017
Ort
Berlin, Irland
104.
 
The Health Technology Assessment Course - Trends & Opportunities in Europe
ID
834301
Beginn
30. Nov 2017
Ort
Brüssel, Belgien
Zusammenfassung
Understand what HTA really means, the different types of HTAs across the EU and what can be expected from it – Learn the optimal HTA process and which criteria for assessment should be applied – Discover multiple solutions for optimising the quality of the evidence.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
105.
 
Principles of Pharma Market Access in Europe
ID
834325
Termin
05. Dez 2017 - 06. Dez 2017
Ort
London, Großbritannien
Zusammenfassung
Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
106.
 
Value Pricing for Market Access - The Fundamentals
ID
834320
Termin
07. Dez 2017 - 08. Dez 2017
Ort
London, Großbritannien
Zusammenfassung
Understand the language, the concepts and pricing research techniques in pharma – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
107.
 
Health Economics for Non-Health-Economists
ID
834371
Termin
14. Dez 2017 - 15. Dez 2017
Ort
Brüssel, Belgien
Zusammenfassung
Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
108.
 
Eilat XIV — Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices
ID
839583
Termin
13. Mai 2018 - 16. Mai 2018
Ort
Madrid, Spanien
Zusammenfassung
Based on the success of the past thirteen Eilat Conferences on New Antiepileptic Drugs and Devices (AEDs), the Organizing Committee takes pleasure in inviting you to participate in the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV), which will take place in Madrid, Spain, May 13 - 16, 2018.

For the forthcoming conference, we will be continuing with debates as well as adhering to the format of the previous conferences which are designed to provide an in-depth progress report on new antiepileptic drugs in various stages of development, as well as to present new findings on second-generation treatments.

Kontakt
Vikki Hyman;     Tel.: [+97235175150];     Email: eilat@target-conferences.com
Themen
epilepsy, antiepileptic, drugs, devices, treatments, conference, congress
Verwandte Fachgebiete
RNA Therapeutics conference
Superbugs & Superdrugs Conference

Interessant...

Ihr Banner-Ad könnte an dieser Stelle erscheinen!

Stand vom 21. Januar 2017